Koselugo Interactions
There are 262 drugs known to interact with Koselugo (selumetinib), along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 77 are major, 184 are moderate, and 1 is minor.
- View all 262 medications that may interact with Koselugo
- View Koselugo alcohol/food interactions (1)
- View Koselugo disease interactions (2)
Most frequently checked interactions
View interaction reports for Koselugo (selumetinib) and the medicines listed below.
- acetaminophen
- Actemra (tocilizumab)
- acyclovir
- Adalat (nifedipine)
- Adderall (amphetamine / dextroamphetamine)
- adenovirus vaccine
- Aerospan HFA (flunisolide)
- Afinitor Disperz (everolimus)
- albuterol
- alprazolam
- amitriptyline
- amoxicillin
- Anucort-HC (hydrocortisone topical)
- Apri (desogestrel / ethinyl estradiol)
- Atarax (hydroxyzine)
- Augmentin (amoxicillin / clavulanate)
- Austedo (deutetrabenazine)
- Cymbalta (duloxetine)
- doxycycline
- enalapril
- fluoxetine
- gabapentin
- Lexapro (escitalopram)
- Lyrica (pregabalin)
- Nucynta (tapentadol)
- omeprazole
- prednisone
- Repatha (evolocumab)
- tramadol
- Vyvanse (lisdexamfetamine)
Koselugo alcohol/food interactions
There is 1 alcohol/food interaction with Koselugo (selumetinib).
Koselugo disease interactions
There are 2 disease interactions with Koselugo (selumetinib) which include:
Report options
More about Koselugo (selumetinib)
- Koselugo consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Alunbrig
Alunbrig (brigatinib) is used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic ...
Gomekli
Gomekli (mirdametinib) is a treatment for neurofibromatosis type 1 with plexiform neurofibromas ...
Augtyro
Augtyro (repotrectinib) is a next-generation TKI (Tyrosine Kinase Inhibitor) cancer medicine used ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Caprelsa
Caprelsa (vandetanib) is used to treat thyroid cancer that cannot be removed by surgery or that has ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
